Study of Refractory and/or Relapsing TAkayasu aRTeritis
Condition(s):Systemic Vasculitis; Arteritis, Takayasu; ArteritisLast Updated:June 26, 2018Recruiting
Hide Studies Not Open or Pending
Condition(s):Systemic Vasculitis; Arteritis, Takayasu; ArteritisLast Updated:June 26, 2018Recruiting
Condition(s):Arteritis, Giant Cell; Blindness and Low VisionLast Updated:February 15, 2019Unknown status
Condition(s):Giant Cell ArteritisLast Updated:July 17, 2015Completed
Condition(s):Giant Cell ArteritisLast Updated:March 25, 2015Completed
Condition(s):Giant Cell ArteritisLast Updated:December 2, 2022Completed
Condition(s):Giant Cell ArteritisLast Updated:March 28, 2022Terminated
Condition(s):Giant Cell ArteritisLast Updated:January 24, 2018Completed
Condition(s):ArteritisLast Updated:September 22, 2005Unknown status
Condition(s):Takayasu Arteritis; Tocilizumab; Adalimumab; TreatmentLast Updated:August 10, 2021Recruiting
Condition(s):Giant Cell Arteritis; AortitisLast Updated:February 21, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.